The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting

<table>The 200 mg/kg X3 Tandem dose predicted (2.5 hr) versus obtained exposures from 1, 1.5, and 2.5 hrs interval.</table>

Journal of Drug Delivery

fig8

Figure 8

Figure 8: The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 

Figure 8 | The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 